Combination Iron Chelation Therapy with Deferiprone and Deferasirox in Iron-Overloaded Patients with Transfusion-Dependent β-Thalassemia Major

There are few papers on the combination therapy of deferiprone (DFP) and deferasirox (DFX) in iron-overloaded patients with transfusion-dependent β-thalassemia major (β-TM). A total of 6 patients with β-TM (5 males and 1 female) with a mean age of 23.8±5.8 years (ranging from 17 to 31) used this tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Karami, Hossein, Kosaryan, Mehrnoush, Amree, Arash Hadian, Darvishi-Khezri, Hadi, Mousavi, Masoomeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2017
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264545/
https://www.ncbi.nlm.nih.gov/pubmed/28243431
http://dx.doi.org/10.4081/cp.2017.912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264545/
https://www.ncbi.nlm.nih.gov/pubmed/28243431
http://dx.doi.org/10.4081/cp.2017.912

Ejemplares similares